Gemphire Therapeutics Inc (GEMP)
0.30 unch (-0.37%) 12/31/19 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Mon, Dec 30th, 2019
Results
download Want to compare other data? Select Fields| Symbol | GEMP | MBIO | RKDA | ||
| Company | Gemphire Therapeutics Inc | Mustang Bio Inc | Arcadia Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.31 | 1.3600 | 3.21 | ||
| High | 0.34 | 1.4000 | 3.21 | ||
| Low | 0.29 | 1.3400 | 3.02 | ||
| Last | 0.30 | 1.3900 | 3.20 | ||
| Change | unch | +0.0500 | +0.21 | ||
| % Change | -0.37% | +3.73% | +7.02% | ||
| Volume | 191,000 | 40,200 | 6,500 | ||
| 20-Day Average Volume | 125,430 | 70,250 | 5,145 | ||
| Previous Close | 0.30 | 1.3400 | 2.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.31 | 1.3662 | 3.07 | ||
| 20-Day Raw Stochastic | 41.64% | 66.69% | 70.52% | ||
| 20-Day Relative Strength | 43.77% | 34.87% | 45.27% | ||
| Weighted Alpha | -67.70 | -92.82 | -37.00 | ||
| Today's Opinion | 100% Sell | 88% Sell | 64% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 96% Sell | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/20/19 | +13.93% since 04/04/25 | +17.22% since 04/04/25 | ||
| Low | 0.28 on 12/27/19 | 1.1700 on 04/07/25 | 2.53 on 04/09/25 | ||
| High | 0.34 on 12/30/19 | 1.4200 on 04/10/25 | 3.21 on 04/11/25 | ||
| 1-Month | |||||
| %Chg | -16.43% since 11/29/19 | -8.55% since 03/11/25 | -1.54% since 03/11/25 | ||
| Low | 0.24 on 12/06/19 | 1.1500 on 04/04/25 | 2.53 on 04/09/25 | ||
| High | 0.39 on 12/03/19 | 1.5475 on 03/13/25 | 3.48 on 03/20/25 | ||
| 3-Month | |||||
| %Chg | -21.42% since 09/30/19 | -89.17% since 01/10/25 | -36.00% since 01/10/25 | ||
| Low | 0.24 on 12/06/19 | 1.1500 on 04/04/25 | 2.53 on 04/09/25 | ||
| High | 0.44 on 10/22/19 | 12.0000 on 01/13/25 | 5.30 on 01/22/25 | ||
| 6-Month | |||||
| %Chg | -62.96% since 06/28/19 | -87.42% since 10/11/24 | +13.88% since 10/11/24 | ||
| Low | 0.24 on 12/06/19 | 1.1500 on 04/04/25 | 2.53 on 04/09/25 | ||
| High | 1.11 on 07/25/19 | 21.9450 on 01/02/25 | 10.31 on 12/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,462 | 4,595 | 4,374 | ||
| Shares Outstanding, K | 14,872 | 3,306 | 1,367 | ||
| Annual Sales | 0 | 0 | 5,050,000 | ||
| Annual Net Income | -23,640,000 | -15,750,000 | -7,040,000 | ||
| Last Quarter Sales | 0 | 0 | 950,000 | ||
| Last Quarter Net Income | -3,430,000 | -950,000 | -4,060,000 | ||
| 60-Month Beta | 2.83 | 2.14 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -2.00 on 11/08/24 | -0.87 on 11/12/24 | ||
| Latest Earnings Date | 01/02/20 | 05/21/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||